NCT02390635 2026-04-17
PET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed Acute Myeloid Leukemia
M.D. Anderson Cancer Center
Phase 1 Recruiting
Clinical Trials
9 trialsNCT07504458 2026-04-16
QUATRO-APL
Quetzal Therapeutics
Phase 3 Recruiting
NCT02390752 2026-04-14
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
National Institutes of Health Clinical Center (CC)
Phase 1 Recruiting
NCT01409161 2025-12-17
Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT04687176 2025-06-12
Frontline Oral Arsenic Trioxide for APL
The University of Hong Kong
Phase 2 Recruiting
NCT06982274 2025-05-30
IC-APL2020
Instituto do Cancer do Estado de São Paulo
Phase 2 Recruiting
NCT05832320 2024-05-10
Optimum Induction Therapy of Low-risk APL
Peking University People's Hospital
Phase NA Recruiting
NCT04793919 2024-04-15
Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia
Associazione Italiana Ematologia Oncologia Pediatrica
Phase 2 Recruiting
NCT04897490 2024-01-09
RWE of 1st Line Treatment With ATO/ATRA for Adult APL
Grupo Argentino de Tratamiento de la Leucemia Aguda
Recruiting